Sou Hu Cai Jing·2025-09-17 20:10Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Fosun Pharma (02196.HK) by 4.086 million shares on September 17, 2025, marking a decrease of 1.27% in their total holdings [1][2] - Over the past five trading days, southbound funds have reduced their holdings on three occasions, resulting in a cumulative net reduction of 2.5952 million shares [1][2] - In the last twenty trading days, there have been fifteen days of reductions, with a total net decrease of 27.6502 million shares [1][2] Group 2 - As of now, southbound funds hold 319 million shares of Fosun Pharma, which accounts for 57.76% of the company's total issued ordinary shares [1][2] - Fosun Pharma operates in five segments, including pharmaceuticals, medical devices and diagnostics, healthcare services, pharmaceutical distribution and retail, and other pharmaceutical-related businesses [2] - The company's products primarily target treatment areas such as oncology, immunology, and central nervous system disorders [2]